Display options
Share it on

Am J Hum Genet. 2002 Jun;70(6):1446-58. doi: 10.1086/340608. Epub 2002 Apr 24.

Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy.

American journal of human genetics

Ercan Demir, Patrizia Sabatelli, Valérie Allamand, Ana Ferreiro, Behzad Moghadaszadeh, Mohamed Makrelouf, Haluk Topaloglu, Bernard Echenne, Luciano Merlini, Pascale Guicheney

Affiliations

  1. INSERM U 523, Groupe Hospitalier Pitié-Salpêtrière, 47 boulevard de l'Hôpital, 75651 Paris cedex 13, France.

PMID: 11992252 PMCID: PMC419991 DOI: 10.1086/340608

Abstract

Ullrich congenital muscular dystrophy (UCMD) is an autosomal recessive disorder characterized by generalized muscular weakness, contractures of multiple joints, and distal hyperextensibility. Homozygous and compound heterozygous mutations of COL6A2 on chromosome 21q22 have recently been shown to cause UCMD. We performed a genomewide screening with microsatellite markers in a consanguineous family with three sibs affected with UCMD. Linkage of the disease to chromosome 2q37 was found in this family and in two others. We analyzed COL6A3, which encodes the alpha3 chain of collagen VI, and identified one homozygous mutation per family. In family I, the three sibs carried an A-->G transition in the splice-donor site of intron 29 (6930+5A-->G), leading to the skipping of exon 29, a partial reduction of collagen VI in muscle biopsy, and an intermediate phenotype. In family II, the patient had an unusual mild phenotype, despite a nonsense mutation, R465X, in exon 5. Analysis of the patient's COL6A3 transcripts showed the presence of various mRNA species-one of which lacked several exons, including the exon containing the nonsense mutation. The deleted splice variant encodes collagen molecules that have a shorter N-terminal domain but that may assemble with other chains and retain a functional role. This could explain the mild phenotype of the patient who was still ambulant at age 18 years and who showed an unusual combination of hyperlaxity and finger contractures. In family III, the patient had a nonsense mutation, R2342X, causing absence of collagen VI in muscle and fibroblasts, and a severe phenotype, as has been described in patients with UCMD. Mutations in COL6A3 are described in UCMD for the first time and illustrate the wide spectrum of phenotypes which can be caused by collagen VI deficiency.

References

  1. Hum Mol Genet. 1998 Jun;7(6):981-9 - PubMed
  2. Hum Mol Genet. 1998 May;7(5):807-12 - PubMed
  3. Am J Hum Genet. 1998 Sep;63(3):861-9 - PubMed
  4. Nat Genet. 1998 Sep;20(1):92-5 - PubMed
  5. Mutat Res. 1998 Sep;411(2):87-117 - PubMed
  6. Hum Mol Genet. 1998 Dec;7(13):2135-40 - PubMed
  7. Am J Hum Genet. 1999 Jan;64(1):126-35 - PubMed
  8. Biochem Biophys Res Commun. 1999 May 19;258(3):802-7 - PubMed
  9. Neuromuscul Disord. 1999 Jun;9(4):264-71 - PubMed
  10. Neuropediatrics. 1999 Apr;30(2):55-65 - PubMed
  11. Neuromuscul Disord. 1999 Jul;9(5):326-9 - PubMed
  12. Exp Cell Res. 1999 Aug 1;250(2):548-57 - PubMed
  13. J Biol Chem. 1999 Jul 30;274(31):21817-22 - PubMed
  14. Am J Hum Genet. 2000 Feb;66(2):428-35 - PubMed
  15. Neuromuscul Disord. 1999 Oct;9(6-7):376-82 - PubMed
  16. Ann Neurol. 2001 Aug;50(2):261-5 - PubMed
  17. Neuromuscul Disord. 1997 Dec;7(8):539-47 - PubMed
  18. FASEB J. 2000 Apr;14(5):761-8 - PubMed
  19. Brain. 2001 Apr;124(Pt 4):698-704 - PubMed
  20. Ann Neurol. 2001 Apr;49(4):544 - PubMed
  21. Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7516-21 - PubMed
  22. Matrix Biol. 2001 Nov;20(7):475-86 - PubMed
  23. Neuropediatrics. 1981 Aug;12(3):197-208 - PubMed
  24. Biochem J. 1983 May 1;211(2):295-302 - PubMed
  25. Biochem J. 1983 May 1;211(2):303-11 - PubMed
  26. J Cell Biol. 1988 Nov;107(5):1995-2006 - PubMed
  27. J Biol Chem. 1988 Dec 15;263(35):18601-6 - PubMed
  28. Am J Med Genet. 1988 Dec;31(4):933-42 - PubMed
  29. J Neurol. 1989 Feb;236(2):108-10 - PubMed
  30. J Biol Chem. 1989 Dec 5;264(34):20235-9 - PubMed
  31. EMBO J. 1990 Feb;9(2):385-93 - PubMed
  32. Biochem J. 1990 Jul 1;269(1):175-81 - PubMed
  33. J Biol Chem. 1991 May 5;266(13):8626-33 - PubMed
  34. EMBO J. 1992 Dec;11(12):4281-90 - PubMed
  35. J Biol Chem. 1992 Nov 25;267(33):24082-9 - PubMed
  36. Gene. 1994 Apr 20;141(2):171-7 - PubMed
  37. Neuromuscul Disord. 1994 Sep-Nov;4(5-6):503-11 - PubMed
  38. Lab Invest. 1995 Jun;72(6):715-22 - PubMed
  39. Nat Genet. 1995 Oct;11(2):216-8 - PubMed
  40. Nat Genet. 1996 Sep;14(1):113-5 - PubMed
  41. J Cell Biochem. 1996 Aug;62(2):227-39 - PubMed
  42. Exp Cell Res. 1996 Nov 1;228(2):283-91 - PubMed
  43. J Biol Chem. 1997 Apr 18;272(16):10769-76 - PubMed
  44. Hum Mol Genet. 1997 May;6(5):747-52 - PubMed
  45. J Biol Chem. 1997 Oct 17;272(42):26522-9 - PubMed
  46. J Biol Chem. 1998 Mar 27;273(13):7423-30 - PubMed
  47. J Med Genet. 1998 Mar;35(3):211-7 - PubMed
  48. Brain Dev. 1998 Mar;20(2):65-74 - PubMed
  49. Hum Hered. 1998 Jul-Aug;48(4):235-6 - PubMed

Substances

MeSH terms

Publication Types